Bladder Cancer Market: Advancing Treatment Through Immunotherapy Innovation
Market Overview The Bladder Cancer Market is experiencing significant growth as immunotherapy emerges as a transformative treatment approach for this challenging malignancy. Bladder cancer ranks as the fourth most common cancer in men and the ninth in women, with approximately 614,000 new cases and over 220,000 deaths globally in 2022 . The development of immune checkpoint inhibitors...
0 Commentarii 0 Distribuiri 7 Views 0 previzualizare